Navigation Links
Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease
Date:4/15/2008

nationwide to automate the WOQ-9 in their waiting room a higher identification rate of wearing-off is anticipated, ideally resulting in subsequent treatment and potentially better patient outcomes.

Physicians who use Phreesia will have the option to seamlessly integrate the WOQ-9 into their existing intake process and evaluate responses at both the patient and practice level. "This is Phreesia at its best -- leveraging evidence-based clinical assessment tools to improve patient care", said Chaim Indig, CEO of Phreesia. The implementation of the WOQ-9 is one of many clinical initiatives that Phreesia is developing for physicians who use their electronic patient check-in system.

About Phreesia:

Phreesia is the patient check-in company. Phreesia automates patient check-in and delivers fully interactive content direct-to-patients, designed to interface with physicians' existing and future technology. Replacing the outdated patient clipboard with a free wireless touch-screen and swipe-card enabled PhreesiaPad significantly improves the patient experience. Phreesia is committed to the ideals of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Phreesia is backed by premier venture capital firms and draws on the expertise of a leading Medical Advisory Board. http://www.phreesia.com


'/>"/>
SOURCE Phreesia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine technology :

1. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
4. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
5. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
6. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
7. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
8. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
9. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
10. Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
11. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wire-FirstCall/ -- ERT (Nasdaq: ERES ), announced... President and CEO, and Keith Schneck, the Company... to present at the 21st Annual Piper Jaffray Healt...09 in New York City, New York. ,, Interested pa...Company,s corporate website at http://www.ert.com...
(Date:11/25/2009)...ire/ -- The FDA granted traditional approval for I...ide reverse transcriptase inhibitor (NNRTI). INTEL...use in treatment-experienced adults who are experi...ant to an NNRTI and other antiretroviral (ARV) age... data from two Phase 3 studies known as DUET-1 and...
(Date:11/25/2009)...RNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a su... APFC ) announced today that it received the Envir...t the Annual Statewide Environmental Summit, spons...y Association (CMTA), the Industrial Environmental...il of California (CICC) held in San Diego. This i...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Stem Cells Grow Heart Tissue in Lab 59556 1Stem Cells Grow Heart Tissue in Lab 59556 2Stem Cells Grow Heart Tissue in Lab 59556 3Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 1Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 2Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 3Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 1Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 2
...inary Phase II Results Encouraging and Support Pha...ternational,Inc. (NYSE: BAX ) and The Alzheimer,s...unced the decision to pursue a multi-center U.S. P...quid [Immune Globulin Intravenous,(Human)] (IGIV),...e,treatment of patients with mild to moderate alzh...
...rack to have Phase 3 data available by the spring ...tion applications expected by the ...28 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) t...d initial dosing ahead of schedule in ACHIEVE 1, t...n(R) (albinterferon alfa-2b) in,combination with r...
Other Medicine Technology:Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 2Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 3Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 4Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 5Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 6Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 2Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 3Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 4Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 5
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allreci...ord-high Thanksgiving traffic numbers, with more t...ng, providing a clear picture of what was served o...e Thanksgiving meal in 2009 weighed in at 2,225 ca... year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...an,orthopedic implants company focused on silicon ... Ashok Khandkar, Ph.D., Chief Executive,Officer, a...f Financial,Officer, are scheduled to present at t...Khandkar and Mr. Gallacher will provide a general ...
...A preparation with no,detectable large RNA and fur... developing area of RNAi, ST....s pleased to introduce mirPremier(TM) microRNA Iso...,purifying and enriching miRNA along with other sm...
...ed those with Lou Gehrig,s disease , , THU...ntibiotic minocycline against amyotrophic lateral ...ed because patients taking the drug had a signific...s such as multiple sclerosis, said a report publis...
...aloon will,host a tribute to the late songwriter W...PM to raise research money and awareness for Mesot...much loved and respected troubadour.,Tickets for t...ds from the show will go to The Mesothelioma Appli...
...anxiety from stressful life situations may be more...ast the first six months after the event, accordin...the journal SLEEP. , The study, authored by Jussi...urbed sleep and 2,572 with disturbed sleep, all of...
...,unveil the successor to its unique Xcelodose syst...and vials at the American Association of,Pharmaceu...o (November 11th,-15th, 2007). The new Xcelodose ...nded software functionality. These enhancements w...
Other Medicine News:Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 2Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 3Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma 2Health News:Anxiety linked to sleep disturbances 2Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2
CX41 Microscopes
CX31 Microscopes
...designed from the ground-up with ergonomic concern...justable observation tube on the market. Optional ...every user can adjust the microscope to suit their...s the operator maintain an upright, comfortable po...
Eclipse TS100F
Medicine Products: